Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Beta-oxidation pathway terminal enzymes" is not a standard name for a single molecular target but rather refers collectively to the enzymes that catalyze the final steps in the beta-oxidation of fatty acids. Beta-oxidation is a mitochondrial process by which fatty acids are broken down into acetyl-CoA, NADH, and FADH₂ for energy production[2][3][5]. The canonical sequence of enzymatic reactions in each cycle includes: 1. Acyl-CoA dehydrogenase (first oxidation) 2. Enoyl-CoA hydratase (hydration) 3. 3-hydroxyacyl-CoA dehydrogenase (second oxidation) 4. β-ketothiolase, also known as thiolase (thiolytic cleavage)[1][3][5] The "terminal enzyme" of each cycle is β-ketothiolase, which cleaves the two-carbon acetyl group from the acyl chain[1][5]. There are multiple isoforms of these enzymes depending on substrate chain length. Because "Beta-oxidation pathway terminal enzymes" does not refer to a specific protein or gene but rather an enzymatic function within a metabolic pathway, it cannot be considered a therapeutic target in itself; instead, individual enzymes within this pathway may be targets or biomarkers for certain metabolic diseases[2][3]. If you require structured information about specific beta-oxidation enzymes—such as "Acyl-CoA dehydrogenase," "Enoyl-CoA hydratase," or "β-ketothiolase"—please specify which enzyme so that detailed data can be provided accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-oxidation pathway terminal enzyme.